- Home
- NKSH vs AMRN Comparison
NKSH vs AMRN Comparison
Compare NKSH & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- AMRN
- Stock Information
- Founded
- NKSH 1891
- AMRN 1989
- Country
- NKSH United States
- AMRN Ireland
- Employees
- NKSH N/A
- AMRN N/A
- Industry
- NKSH Major Banks
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- NKSH Finance
- AMRN Health Care
- Exchange
- NKSH Nasdaq
- AMRN Nasdaq
- Market Cap
- NKSH 190.8M
- AMRN 189.2M
- IPO Year
- NKSH N/A
- AMRN 1993
- Fundamental
- Price
- NKSH $28.88
- AMRN $0.55
- Analyst Decision
- NKSH Strong Buy
- AMRN Buy
- Analyst Count
- NKSH 1
- AMRN 1
- Target Price
- NKSH $38.00
- AMRN N/A
- AVG Volume (30 Days)
- NKSH 11.8K
- AMRN 1.1M
- Earning Date
- NKSH 01-23-2025
- AMRN 02-27-2025
- Dividend Yield
- NKSH 5.22%
- AMRN N/A
- EPS Growth
- NKSH N/A
- AMRN N/A
- EPS
- NKSH 1.24
- AMRN N/A
- Revenue
- NKSH $44,130,000.00
- AMRN $241,021,000.00
- Revenue This Year
- NKSH N/A
- AMRN N/A
- Revenue Next Year
- NKSH $9.78
- AMRN N/A
- P/E Ratio
- NKSH $23.39
- AMRN N/A
- Revenue Growth
- NKSH N/A
- AMRN N/A
- 52 Week Low
- NKSH $26.00
- AMRN $0.43
- 52 Week High
- NKSH $35.00
- AMRN $1.36
- Technical
- Relative Strength Index (RSI)
- NKSH 47.64
- AMRN 50.48
- Support Level
- NKSH $27.66
- AMRN $0.55
- Resistance Level
- NKSH $30.48
- AMRN $0.61
- Average True Range (ATR)
- NKSH 1.04
- AMRN 0.04
- MACD
- NKSH 0.02
- AMRN -0.00
- Stochastic Oscillator
- NKSH 39.48
- AMRN 26.56
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.